RYSBEVI - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
99249858
Word Mark
RYSBEVI
Status
661 - Response After Non-Final Action - Entered
Status Date
2025-09-04
Filing Date
2025-06-24
Mark Drawing
4 - Standard character mark
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
CLARK, ROBERT
Statements
Goods and Services
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations containing viral vectors for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations for gene therapy, gene editing, and genome editing for treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Gene therapies, in the nature of pharmaceutical preparations, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Translation of Words in Mark
The wording RYSBEVI has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2025-06-24
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Maury M Tepper, III Tepper & Eyster, PLLC
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2025-06-24 | NEW APPLICATION ENTERED |
| 2025-06-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2025-06-24 | APPLICATION FILING RECEIPT MAILED |
| 2025-09-02 | ASSIGNED TO EXAMINER |
| 2025-09-02 | NON-FINAL ACTION WRITTEN |
| 2025-09-02 | NON-FINAL ACTION E-MAILED |
| 2025-09-02 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2025-09-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2025-09-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2025-09-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
